-
Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events
Meiring, S., Busch, C. B. E., van Baar, A. C. G., Hemke, R., Holleman, F., Nieuwdorp, M. & Bergman, J. J. G. H. M., 22 Sept 2022, In: Cardiovascular diabetology. 21, 1, 191.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
